Q2 2019 13F Holders as of 6/30/2019
-
Type / Class
-
Equity / American Depositary Shares, each representing 1 Ordinary Shares
-
Shares outstanding
-
100M
-
Number of holders
-
63
-
Total 13F shares, excl. options
-
13.3M
-
Shares change
-
+628K
-
Total reported value, excl. options
-
$208M
-
Value change
-
+$7.74M
-
Put/Call ratio
-
0.91
-
Number of buys
-
34
-
Number of sells
-
-27
-
Price
-
$15.60
Significant Holders of Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares (CLLS) as of Q2 2019
74 filings reported holding CLLS - Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares as of Q2 2019.
Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares (CLLS) has 63 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13.3M shares
of 100M outstanding shares and own 13.27% of the company stock.
Largest 10 shareholders include FMR LLC (4.21M shares), Nikko Asset Management Americas, Inc. (1.22M shares), Sumitomo Mitsui Trust Holdings, Inc. (1.21M shares), ARK Investment Management LLC (1.1M shares), Capital World Investors (875K shares), ARMISTICE CAPITAL, LLC (800K shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (575K shares), MORGAN STANLEY (495K shares), CREDIT SUISSE AG/ (460K shares), and Capital International Investors (421K shares).
This table shows the top 63 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.